Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Hoch

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Cancer Genetics and Cytogenetics|July 13, 2010
A novel case of t(X;1)(p11.2;p34) in a renal cell carcinoma with TFE3 rearrangement and favorable outcome in a 57-year-old patientJuliette Haudebourg, Benjamin Hoch, Thibault Fabas, et al.
Virchows Archiv : an International Journal of Pathology|June 23, 2010
Strength of molecular cytogenetic analyses for adjusting the diagnosis of renal cell carcinomas with both clear cells and papillary features: a study of three casesJuliette Haudebourg, Benjamin Hoch, Thibault Fabas, et al.
Cancer Genetics|November 3, 2012
Renal cell carcinoma and a constitutional t(11;22)(q23;q11.2): case report and review of the potential link between the constitutional t(11;22) and cancerJérôme Doyen, Xavier Carpentier, Juliette Haudebourg, et al.
Archives of Gynecology and Obstetrics|September 2, 2016
Dilatation or no dilatation of the cervix during cesarean section (Dondi Trial): a randomized controlled trialJade Kirscht, Christel Weiss, Jana Nickol, et al.
Cancer Genetics|November 21, 2017
High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 casesRobert W Ricciotti, Aaron J Baraff, George Jour, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroidGlaucia C Furtado, Tatjana Marinkovic, Andrea P Martin, et al.
JCO Oncology Practice|June 11, 2025
EMOTION: Assessing the Impact of a Telephone Intervention for Patients With Breast Cancer, a Randomized Controlled TrialSara Contu, Christophe Hebert, Jean-Marc Ferrero, et al.
The Journal of Pathology|October 10, 2017
Novel enriched pathways in superficial malignant peripheral nerve sheath tumours and spindle/desmoplastic melanomasGeorge Jour, Nicole K Andeen, Rami Al-Rohil, et al.
Bulletin Du Cancer|March 20, 2021
[We must respect the anti-SARS-CoV-2 vaccine schedule without delay in cancer patients under treatment]Jérôme Barrière, Clarisse Audigier-Valette, Delphine Borchiellini, et al.
Urologic Oncology|August 27, 2019
"Real-world" evaluation of <sup>18</sup>F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategyVincent Niziers, Romain Boissier, Delphine Borchiellini, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Cancer Genetics and Cytogenetics|July 13, 2010
A novel case of t(X;1)(p11.2;p34) in a renal cell carcinoma with TFE3 rearrangement and favorable outcome in a 57-year-old patientJuliette Haudebourg, Benjamin Hoch, Thibault Fabas, et al.
Virchows Archiv : an International Journal of Pathology|June 23, 2010
Strength of molecular cytogenetic analyses for adjusting the diagnosis of renal cell carcinomas with both clear cells and papillary features: a study of three casesJuliette Haudebourg, Benjamin Hoch, Thibault Fabas, et al.
Cancer Genetics|November 3, 2012
Renal cell carcinoma and a constitutional t(11;22)(q23;q11.2): case report and review of the potential link between the constitutional t(11;22) and cancerJérôme Doyen, Xavier Carpentier, Juliette Haudebourg, et al.
Archives of Gynecology and Obstetrics|September 2, 2016
Dilatation or no dilatation of the cervix during cesarean section (Dondi Trial): a randomized controlled trialJade Kirscht, Christel Weiss, Jana Nickol, et al.
Cancer Genetics|November 21, 2017
High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 casesRobert W Ricciotti, Aaron J Baraff, George Jour, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroidGlaucia C Furtado, Tatjana Marinkovic, Andrea P Martin, et al.
JCO Oncology Practice|June 11, 2025
EMOTION: Assessing the Impact of a Telephone Intervention for Patients With Breast Cancer, a Randomized Controlled TrialSara Contu, Christophe Hebert, Jean-Marc Ferrero, et al.
The Journal of Pathology|October 10, 2017
Novel enriched pathways in superficial malignant peripheral nerve sheath tumours and spindle/desmoplastic melanomasGeorge Jour, Nicole K Andeen, Rami Al-Rohil, et al.
Bulletin Du Cancer|March 20, 2021
[We must respect the anti-SARS-CoV-2 vaccine schedule without delay in cancer patients under treatment]Jérôme Barrière, Clarisse Audigier-Valette, Delphine Borchiellini, et al.
Urologic Oncology|August 27, 2019
"Real-world" evaluation of <sup>18</sup>F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategyVincent Niziers, Romain Boissier, Delphine Borchiellini, et al.
Pageof 5